Gerresheimer AG (ETR:GXI) has been assigned a €75.00 ($88.24) price target by equities researchers at Berenberg Bank in a research report issued on Wednesday. The firm currently has a “buy” rating on the stock.
GXI has been the subject of a number of other reports. Credit Suisse Group set a €80.00 ($94.12) price objective on Gerresheimer AG and gave the stock a “buy” rating in a report on Tuesday. Hauck & Aufhaeuser set a €63.50 ($74.71) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Thursday, September 21st. Goldman Sachs Group, Inc. (The) set a €73.00 ($85.88) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Friday, June 30th. J P Morgan Chase & Co set a €99.40 ($116.94) target price on Gerresheimer AG and gave the company a “buy” rating in a research note on Thursday, August 31st. Finally, Commerzbank Ag set a €73.00 ($85.88) target price on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of €73.14 ($86.05).
Gerresheimer AG (ETR:GXI) opened at 63.515 on Wednesday. The company has a market capitalization of €1.99 billion and a P/E ratio of 17.594. The firm has a 50-day moving average price of €65.16 and a 200 day moving average price of €70.39. Gerresheimer AG has a 52-week low of €59.97 and a 52-week high of €79.47.
ILLEGAL ACTIVITY NOTICE: “Gerresheimer AG (GXI) Given a €75.00 Price Target by Berenberg Bank Analysts” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/2956633/gerresheimer-ag-gxi-given-a-75-00-price-target-by-berenberg-bank-analysts.html.
Gerresheimer AG Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.